Leading medical organizations team up to bring new TB treatments to those in need
03/19/2015. International organizations Partners In Health (PIH), Médecins Sans Frontières (MSF), Interactive Research and Development (IRD) and their financial partner UNITAID will start in April the endTB project, a partnership aimed at radically changing the management of multidrug-resistant tuberculosis (MDR-TB).
By 2019, endTB will provide access to two new anti-TB drugs (bedaquiline and delamanid), for 2,600 MDR-TB patients in 16 countries. These are the first new anti-TB drugs developed in over 50 years and these drugs offer new hope to patients suffering from MDR-TB.
Read the article on MSF website
Related Articles
EU-Turkey Agreement: the concern of the “Œuvre d’Orient”
03/19/2016. Mgr Pascal Gollnisch, director of the the Œuvre d’Orient expressed his reluctance.
Armed conflicts have displaced 30 million minors worldwide
06/01/2017. Armed conflicts have displaced 30 million minors worldwide. Opening the conference, the Order of Malta’s Grand Hospitaller Dominique de La Rochefoucauld-Montbel said that children were the first victims of wars and persecutions.
One year after humanitarian summit, UN stresses reforms to put people ‘at heart’ of decision-making
05/23/2017. The international community must use resources better and galvanize new partnerships, top United Nations officials said today.
